-+ 0.00%
-+ 0.00%
-+ 0.00%

Benitec Biopharma appoints David Friedman to board

PUBT·05/29/2026 20:12:35
Listen to the news
Benitec Biopharma appoints David Friedman to board
  • Benitec Biopharma named David Friedman to its board as a Class III director, effective May 22, 2026, with a term running to 2028.
  • CFO and secretary Megan Boston resigned from the board effective May 22, 2026, as part of a board composition review.
  • Boston will remain CFO and secretary; her board exit was not tied to any dispute with the company.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Benitec Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-248289), on May 29, 2026, and is solely responsible for the information contained therein.